ABSTRACT. The effect of opiate receptor blockade on the plasma catecholamine response to hypoxemia was studied in seven chronically catheterized fetal lambs in utero. All animals underwent treatment with hypoxia alone, naloxone infusion alone (2 mglkg) and hypoxia with naloxone at four different dosages (0.1, 0.5, 1.0, and 2.0 mglkg). Maternal and fetal hypoxia was maintained for 20 min. There were no differences noted in the degree of hypoxemia or acidemia between the different hypoxia treatment groups. Hypoxia increased both norepinephrine and epinephrine plasma levels in all fetal sheep studied. We found a dose-dependent increase in plasma epinephrine levels in response to naloxone infusion during hypoxia. Plasma epinephrine level by 20 min of hypoxia with the 0.1 mg/kg naloxone dose (geometric mean 5366 pg/ml) was significantly more than with hypoxia alone (997 pglml). Naloxone at the other doses did not alter the epinephrine responses. There was no augmentation of plasma norepinephrine levels by naloxone at any dose studied. Thus, naloxone augmented the plasma epinephrine response to hypoxia in fetal sheep suggesting that the opiate peptides act as modulators of the sympathoadrenal system. The naloxone dose response differences observed in this study suggest this modulation is largely by antagonism of p-receptors. (Pediatr Res 23: 343-347,1988) Abbreviations ANOVA, analysis of variance SNK, Student-Newman-Keuls test HR, heart rate Marked increases in plasma catecholamines have been described in fetal and newborn animals in response to hypoxia (I), hypothermia (2), hemorrhage (3), labor (4), and birth (5, 6). Catecholamine release has been shown to be important for cardiovascular, pulmonary, and metabolic adjustments during neonatal adaptation to extrauterine life (7). In addition, the ability of neonatal rats to survive acute asphyxia depends on the release of catecholamines (8). The endogenous opiate peptides (enkephalins and endorphins) have also been postulated to func- tion as modulators of the cardiovascular response to stress. Circulating plasma levels of opiate peptides increase in response to hypoxia (9), asphyxia (10, 1 l), central nervous system hemorrhage (1 2), shock ( l3), and labor and delivery ( 14, 15). Opiate peptide antagonists have been shown to reverse cardiovascular collapse in hemorrhagic and endotoxin shock (16).
tion as modulators of the cardiovascular response to stress. Circulating plasma levels of opiate peptides increase in response to hypoxia (9) , asphyxia (10, 1 l), central nervous system hemorrhage (1 2), shock ( l3), and labor and delivery ( 14, 15) . Opiate peptide antagonists have been shown to reverse cardiovascular collapse in hemorrhagic and endotoxin shock (16) .
Neuropharmacologic studies suggest an important physiologic role for opiate peptides as modulators of sympathoadrenal activity. Opiate peptides inhibit neurotransmission in sympathetic ganglia (17, 18) as well as adrenal medullary catecholamine release in vitro (19) and in vivo (20) . Endogenous opiates in the CNS also inhibit sympathoadrenal activity (2 1). We have recently demonstrated that pharmacologic blockade of endogenous opiate receptors is associated with an increase in catecholamine release at birth (22) .
In order to extend these observations and to study the factors that regulate fetal catecholamine release during perinatal stress, we designed experiments to investigate the effect of endogenous opiate peptide blockade on plasma catecholamine release in fetal sheep in response to hypoxia.
MATERIALS AND METHODS
Surgical procedures. Seven time-dated pregnant ewes with singleton pregnancies were catheterized at 1 18-122 days of gestation (term 150 days). The ewes were sedated with ketamine (800 mg) and atropine (1.2 mg) and received a constant infusion of ketamine (8-10 mg/min) for the duration of the operation. The fetal hindlimb was exteriorized through a uterine incision and polyvinyl catheters were placed in an artery and vein after local anesthesia. The catheters were advanced to the level of the descending aorta and inferior cava, respectively. An additional catheter was placed in the uterus to allow measurement of amniotic fluid pressure. The uterine incision was closed with all catheters tunneled subcutaneously in the maternal flank and stored in a cloth pouch sewn to the skin of the ewe. The ewe had catheters placed into the femoral vein and artery. These were also tunneled subcutaneously and stored with the fetal catheters. Oxacillin and gentamycin were given intravenously for 3 days postoperatively to both mother and fetus. Animals were allowed to recover a minimum of 3-5 days before any studies were performed.
Experimental protocol. On the day of study, the fetal arterial catheter and intrauterine catheter were connected to Statham P23dB pressure transducers that were attached to a Sensormedics R6 1 1 rectilinear polygraph. Fetal arterial blood gas, hematocrit, fetal systolic blood pressure, mean blood pressure, and amniotic fluid pressure were observed for a minimum of 30 min before any experimental manipulation. At that time, fetal HR and blood pressure were recorded, and duplicate arterial blood samples 344 MARTINEZ ET AL.
were obtained for baseline catecholamine values and blood gas analyses. Fetal arterial pressures were corrected by subtracting amniotic fluid pressure. After obtaining the baseline samples, the experimental protocol commenced. All fetal sheep were randomly assigned the order in which they were studied. On separate days each fetus underwent saline infusion alone, naloxone alone (2 mg/kg), hypoxia alone, or hypoxia with naloxone infusion at 0.1, 0.5, 1.0, and 2.0 mg/kg. The naloxone infusions were given as an initial intravenous bolus (mg/kg) and then followed by a constant infusion at the same dose (mg/kg/h). All animals underwent each protocol and were allowed to recover 1-2 days between studies. Fetal sheep were studied between 122 and 142 days of gestation (Table 1) . Hypoxia was produced by securing a clear plastic bag over the ewe's head and delivering a gas mixture of nitrogen and oxygen. The FI02 of the inspired gas mixture was in the range of 10-12%. The fetal PaOl was monitored and oxygen delivery was adjusted to maintain hypoxemia in the range of 12-14 mm Hg in the fetus.
Fetal arterial blood samples drawn after 10 and 20 min of hypoxia for measurements of plasma catecholamines were added to chilled test tubes containing EGTA and reduced glutathione. The samples were centrifuged immediately. The plasma was separated and stored at -70" C until catecholamine analysis was performed. Plasma catecholamine concentrations were determined by radioenzymatic assay sensitive to 1-2 pg of norepinephrine and epinephrine as previously described (6, 7, 23) . Arterial blood gases were recorded at each interval. Approximately 4 ml of blood was removed at each sample period and replaced with heparinized maternal blood that had been drawn before any experimental manipulation. Fetal weight was estimated using a formula previously described for fetal sheep (24) .
Data analysis. Norepinephrine and epinephrine levels were log transformed before statistical analysis. Plasma norepinephrine and epinephrine levels are expressed as geometric mean concentrations (pg/ml) + SEM. Other data are presented as mean + SEM. ANOVA was used for comparisons between groups and statistical differences were determined using the SNK. Two-way ANOVA for repeated measures was used for comparison of plasma catecholamine values during hypoxia between the different treatment groups.
RESULTS
Baseline values for all fetuses for norepinephrine (4 18 + 23 pg ml) and epinephrine (9 k 2 pg/ml), HR (157 k 5 bpm), systolic blood pressure (77 + 1 mm Hg), pH (7.36 f 0.03), and p 0 2 (22 + 0.5 mm Hg) were similar to data previously reported by our laboratory and others (1, 4, 7, 22) . All fetuses underwent each protocol. By allowing 1-2 days rest period between studies, we found that catecholamine levels, HR, and blood pressure on subsequent studies did not vary significantly and had returned to values found in unstressed animals ( Hypoxia studies. Fetal PaOz decreased significantly during exposure to the hypoxic gas mixture at 10 and 20 min ( Table 2 ). The decrement in p 0 2 was comparable in all the animals exposed to hypoxia ( p > 0.05, ANOVA). There was no change in either the saline control group (25 + 1 mm Hg) or the naloxone alone control group (22 f 1 mm Hg) when compared to baseline levels. Figure 2 shows the epinephrine levels at 10 and 20 min after hypoxia alone and hypoxia plus naloxone at four different dosages. All epinephrine responses during hypoxia were significantly greater than the responses after treatment with saline or naloxone alone. Plasma epinephrine levels during the 0.1 mg/kg naloxone dose were significantly greater than with hypoxia alone ( p < 0.05, two-way ANOVA). The geometric mean epinephrine level by 20 min was 5366 f 3 144 pg/ml during hypoxia with 0.1 mg/ kg naloxone versus 997 + 98 1 pg/ml at 20 min during hypoxia alone. The plasma norepinephrine levels at 10 and 20 min after hypoxia alone and hypoxia plus naloxone at four different dosages are shown in Figure 3 . As noted for epinephrine responses, all norepinephrine responses during hypoxia were significantly greater than those after treatment with saline alone or naloxone alone. There were no differences in plasma norepinephrine responses among the different naloxone treatment groups during hypoxia. Despite the induced hypoxemia, there were no statistical differences in systemic pH when comparing the different treatment groups at 10 and 20 min.
DISCUSSION
Herein we demonstrated a marked augmentation in plaSma epinephrine response when fetal sheep were treated with a 0.1 mg/kg bolus and 0.1 mg/kg/h infusion of naloxone during hypoxemia. We noted both fetal hypertension and reflex bradycardia associated with hypoxia. The increase in blood pressure in the low dose naloxone group was greater than any other treatment group or the hypoxia control but this difference was just at the level of statistical significance. It is likely that more repetitive measures of blood pressure would have demonstrated a statistically significant difference. The continuing bradycardia in the low dose naloxone group probably represents a reflex response to the sustained elevation in blood pressure. Previous studies have shown a decrease in HR in animals exposed to hypoxia (25, 26) . Moreover, the use of naloxone during hypoxia has been shown to further exaggerate this bradycardic response (25) . Atropine has been shown to reverse this effect (25) . Under normoxemic conditions, naloxone alone did not affect blood pressure, HR, or plasma catecholamine levels.
The role of opiate peptides as modulators of sympathoadrenal activity has been the subject of recent investigations. The opiate peptides and their receptors have been identified in CNS areas important for cardiovascular and respiratory control (1 6) as well as in sympathetic ganglia (27) and the adrenal medulla (28) of many species. This distribution suggests possible interactions with the sympathoadrenal system. In sympathetic ganglia, opiate peptides inhibit norepinephrine release through presynaptic inhibition of cholinergic transmission probably through reduced acetylcholine release (17, 18) . Opiate peptides also reduce the response of peripheral organs to electrical field stimulation from a presumed receptor-mediated inhibition of acetylcholine and norepinephrine release (29) . Adrenal medullary cells in vitro release catecholamines in response to cholinergic stimulation. Endogenous opiates inhibit this response and are effective at concentrations comparable to those observed during physiologic states (19) . Endogenous opiates in the central nervous system also inhibit sympathoadrenal activity (2 1) and this effect can be blocked by CNS doses of opiate receptor blockers which have no effect when administered peripherally (30, 3 1) .
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In vivo, plasma catecholamines have been measured before and after induced hemorrhage in adult rabbits and after naloxone administration. Naloxone caused a nearly 100% increase in circulating norepinephrine and return of blood pressure to normal with a smaller increase in plasma epinephrine (32) . In adult humans with septic shock, naloxone administration evoked a 10-fold increase in plasma epinephrine levels associated with improvements in circulatory function (33) . Similar improvements in blood pressure and peripheral perfusion after naloxone have been observed in septic newborn humans (34, 35) . In adult rats, the beneficial effects of naloxone during hemorrhagic shock are blocked by adrenalectomy (3 1). In contrast, fentanyl, a potent opiate agonist, causes a dose-dependent inhibition of plasma norepinephrine and epinephrine in humans (36, 37) and adult dogs (38) as well as decreases in HR, blood pressure, and cardiac output. However, the effects of opiate peptides are complex and their excitatory or inhibitory effects depend on the site of administration, the concomitant use of anesthesia, the species studied, the type of receptor affected, and the dose administered (16) . In contrast to the present results, intracisternal administration of pendorphin in unanesthetized rats is associated with an increase in circulating norepinephrine, epinephrine, and dopamine (39) . Moreover, both pressor and depressor responses have been observed in response to the same opiate peptide injected into neighboring paraventricular regions less than 1 mm apart (40) .
An important finding herein was the apparent differential activation by naloxone of epinephrine release from the adrenal gland. Previous studies have also suggested both differential epinephrine (33) and norepinephrine (32) responses. Whether these represent species differences or are due to differences in experimental models is unclear. There are well-described maturational changes in control of adrenal function during fetal and newborn life. Adrenal catecholamine release during hypoxia has been shown to occur by two separate mechanisms. A nonneurogenic mechanism, independent of splanchnic innervation, is seen in fetal sheep up until the last 20 days of intrauterine gestation (41) and in newborn rats up to 8 days postnatally (8) . With the development of splanchnic nerve innervation, there is an increase in the magnitude of catecholamine release and an increase in the proportion of epinephrine. It is possible that the selective epinephrine response to naloxone during hypoxia reflects the level of maturation attained by the fetal sheep at the time of study or that hypoxia may selectively result in an opiate peptide "limit" on adrenal epinephrine release. Whether there would be a difference in the magnitude of response to naloxone or in the selective release of either norepinephrine or epinephrine during very early fetal life compared to term animals is not answered by our study. Additional studies are needed to further elucidate the physiologic role of the opiate peptides and the maturational changes that occur in the sympathoadrenal system.
Herein we observed a marked dose response difference. Naloxone at a low dosage was shown to potentiate the plasma epinephrine response to hypoxia whereas no effect was observed at higher doses. Multiple opiate receptor subtypes are now recognized (40, 42) . Whereas overlap exists because endogenous opiates and pharmacologic agents have only relative selectivity for one receptor over another, some generalizations do exist. Mu-receptors generally mediate analgesic and vasodepressive effects while &receptors mediate pressor-type cardiovascular effects. Naloxone is a competitive opiate receptor antagonist (42) with approximately 10-fold greater affinity for p than 6 receptors (43, 44) . Thus our results are consistent with the interpretation that naloxone at the lowest dose was antagonizing p-receptormediated inhibition of catecholamine release. At the highest dose naloxone may have been blocking a &receptor-mediated increase in sympathoadrenal activity and catecholamine release. This is in agreement with previous data on the effect of high dose naloxone on plasma catecholamines during brief periods of hypoxia induced by umbilical cord occlusion in sheep (26) .
In conclusion, we found hypoxia to be a significant stimulus for epinephrine release in fetal sheep and that low level naloxone treatment augments this release. Our data suggest that hypoxia increases endogenous opiate peptide release and that opiate peptides in turn affect the cardiovascular response of fetal sheep by inhibiting the sympathoadrenal system. Further studies are necessary to clarify the mechanisms involved as well as the physiologic importance of the interaction of these two systems.
